Abbott Laboratories

Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon and happy […]
Read More
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
A sign with the company logo outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Earlier this […]
Read More
Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
A man wearing Abbott’s Lingo biosensor. Courtesy of Abbott Abbott Laboratories announced Thursday its over-the-counter continuous glucose monitor Lingo is available in the U.S. starting at $49. Lingo is part of an emerging class of consumer-friendly biosensors that people can use to learn how their bodies respond to food, exercise, sleep and stress. These devices, […]
Read More
Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like
Zoom In IconArrows pointing outwards User wearing Stelo CGM from Dexcom. Courtesy of Dexcom Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S. Glucose is a type of sugar people receive from food, and it’s the body’s main source of energy. Continuous glucose monitors, or […]
Read More
Jim Cramer looks at reasons for the market decline and provides new views on 3 stocks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets drop: Wall Street struggled to hold onto its early gains and moved lower. We’re not surprised to see the market take a breather after its […]
Read More
An ugly earnings report from a competitor is good news for Abbott Labs
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Stocks jumped Friday as Wall Street tried to end a turbulent week on a jubilant note. The Dow Jones Industrial Average added more more than 600 points, or 1.6%. The […]
Read More
Catalyst calendar: Here’s a look at major events that could propel these 7 stocks higher
AI tech stocks have been on the rage on Wall Street. But here are some events that could lift other Club names higher in the weeks and months ahead. Source
Read More
Fda approves two new Abbott above-the-counter steady glucose monitors
Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced on Monday it obtained acceptance from the U.S. Food items and Drug Administration for two new constant […]
Read More